News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
193,974 Results
Type
Article (9320)
Company Profile (21)
Press Release (184632)
Multimedia
Podcasts (5)
Webinars (2)
Section
Business (58972)
Career Advice (656)
Deals (11201)
Drug Delivery (21)
Drug Development (29050)
Employer Resources (40)
FDA (4973)
Job Trends (4578)
News (101930)
Policy (8111)
Tag
Academia (504)
Accelerated approval (3)
Adcomms (6)
Allergies (48)
Alliances (7926)
ALS (62)
Alzheimer's disease (621)
Antibody-drug conjugate (ADC) (74)
Approvals (5101)
Artificial intelligence (177)
Autoimmune disease (24)
Automation (11)
Bankruptcy (78)
Best Places to Work (4095)
BIOSECURE Act (3)
Biosimilars (77)
Biotechnology (20)
Bladder cancer (86)
Brain cancer (20)
Breast cancer (277)
Cancer (1904)
Cardiovascular disease (142)
Career advice (534)
Career pathing (8)
CAR-T (82)
CDC (6)
Cell therapy (219)
Cervical cancer (17)
Clinical research (26360)
Collaboration (552)
Company closure (1)
Compensation (429)
Complete response letters (6)
COVID-19 (858)
CRISPR (30)
C-suite (165)
Cystic fibrosis (47)
Data (2248)
Denatured (1)
Depression (34)
Diabetes (183)
Diagnostics (1871)
Digital health (12)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (61)
Drug pricing (33)
Drug shortages (11)
Duchenne muscular dystrophy (96)
Earnings (46287)
Editorial (13)
Employer branding (8)
Employer resources (35)
Events (28928)
Executive appointments (404)
FDA (6222)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (488)
Gene editing (59)
Generative AI (4)
Gene therapy (181)
GLP-1 (384)
Government (1165)
Grass and pollen (3)
Guidances (316)
Healthcare (5308)
HIV (31)
Huntington's disease (10)
IgA nephropathy (22)
Immunology and inflammation (78)
Immuno-oncology (4)
Indications (27)
Infectious disease (947)
Inflammatory bowel disease (62)
Inflation Reduction Act (3)
Influenza (34)
Intellectual property (56)
Interviews (125)
IPO (7164)
IRA (13)
Job creations (785)
Job search strategy (463)
Kidney cancer (10)
Labor market (24)
Layoffs (142)
Leadership (3)
Legal (1481)
Liver cancer (34)
Longevity (2)
Lung cancer (305)
Lymphoma (160)
Machine learning (10)
Management (10)
Manufacturing (181)
MASH (51)
Medical device (4122)
Medtech (4128)
Mergers & acquisitions (4489)
Metabolic disorders (441)
Multiple sclerosis (78)
NASH (6)
Neurodegenerative disease (65)
Neuropsychiatric disorders (21)
Neuroscience (1018)
NextGen: Class of 2025 (1483)
Non-profit (1057)
Now hiring (8)
Obesity (211)
Opinion (44)
Ovarian cancer (51)
Pain (56)
Pancreatic cancer (78)
Parkinson's disease (101)
Partnered (4)
Patents (138)
Patient recruitment (110)
Peanut (21)
People (6952)
Pharmaceutical (6)
Pharmacy benefit managers (8)
Phase I (6820)
Phase II (11320)
Phase III (10293)
Pipeline (1769)
Policy (42)
Postmarket research (1068)
Preclinical (2137)
Press Release (27)
Prostate cancer (94)
Psychedelics (6)
Radiopharmaceuticals (82)
Rare diseases (228)
Real estate (900)
Recruiting (16)
Regulatory (6707)
Reports (16)
Research institute (493)
Resumes & cover letters (111)
Rett syndrome (9)
RNA editing (1)
RSV (29)
Schizophrenia (60)
Series A (71)
Series B (64)
Service/supplier (3)
Sickle cell disease (38)
Special edition (6)
Spinal muscular atrophy (87)
Sponsored (9)
Startups (635)
State (1)
Stomach cancer (6)
Supply chain (47)
Tariffs (15)
The Weekly (4)
Vaccines (347)
Venture capital (21)
Weight loss (130)
Women's health (19)
Worklife (8)
Date
Today (17)
Last 7 days (203)
Last 30 days (957)
Last 365 days (17251)
2025 (11977)
2024 (14758)
2023 (14315)
2022 (16776)
2021 (16234)
2020 (15541)
2019 (12785)
2018 (9784)
2017 (9333)
2016 (7966)
2015 (9632)
2014 (7086)
2013 (5215)
2012 (5911)
2011 (6161)
2010 (5233)
Location
Africa (218)
Alabama (14)
Alaska (2)
Arizona (59)
Arkansas (5)
Asia (12362)
Australia (2142)
California (4512)
Canada (1145)
China (393)
Colorado (188)
Connecticut (238)
Delaware (168)
Europe (30165)
Florida (517)
Georgia (116)
Hawaii (2)
Idaho (12)
Illinois (337)
India (16)
Indiana (181)
Iowa (11)
Japan (183)
Kansas (54)
Kentucky (13)
Louisiana (8)
Maine (38)
Maryland (447)
Massachusetts (3321)
Michigan (88)
Minnesota (232)
Mississippi (1)
Missouri (52)
Montana (11)
Nebraska (4)
Nevada (58)
New Hampshire (29)
New Jersey (1286)
New Mexico (5)
New York (1167)
North Carolina (566)
North Dakota (3)
Northern California (2078)
Ohio (109)
Oklahoma (5)
Oregon (10)
Pennsylvania (807)
Puerto Rico (3)
Rhode Island (15)
South America (321)
South Carolina (12)
Southern California (1692)
Tennessee (58)
Texas (654)
United States (15631)
Utah (102)
Virginia (110)
Washington D.C. (34)
Washington State (370)
West Virginia (2)
Wisconsin (62)
193,974 Results for "6".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
6 Companies Hiring in Texas
Looking for a biopharma job in Texas? Check out the
BioSpace
list of six companies hiring life sciences professionals like you.
August 14, 2025
·
1 min read
·
Angela Gabriel
Podcast
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More
George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest rejection reportedly driven by FDA’s top cancer regulator Richard Pazdur; Merck’s $3 billion savings push claims 6,000 jobs; and Pfizer CEO Albert Bourla addresses President Donald Trump’s new threats around Most Favored Nation drug pricing.
August 6, 2025
·
2 min read
·
Heather McKenzie
Job Trends
6 Companies Hiring in Illinois
Looking for a biopharma job in Illinois? Check out the
BioSpace
list of six companies hiring life sciences professionals like you.
July 17, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Immunofluorescence Assay Market Size to Surpass USD 6.11 Billion by 2034
September 15, 2025
·
1 min read
IPO
After 2021 SPAC Bubble, How Did These 6 Biotechs Fare?
Some of the biggest SPACs from the industry’s pandemic-fueled heyday are no longer on the market.
September 3, 2025
·
10 min read
·
Tristan Manalac
Press Releases
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
August 29, 2025
·
5 min read
Press Releases
Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds
September 12, 2025
·
5 min read
Press Releases
Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering
August 21, 2025
·
5 min read
Press Releases
PacBio to Present at Upcoming Investor Conferences - August 6, 2025
August 7, 2025
·
1 min read
Press Releases
Schrödinger to Announce Second Quarter 2025 Financial Results on August 6
July 28, 2025
·
1 min read
1 of 19,398
Next
